GILD
60
-3
SJM
21
-8
NWSA
79
-3
ADSK
62
-5
USB
64
-9
AAP
20
-7
MLM
50
-14
KEY
60
-7
MU
62
-2
HBAN
74
-10
TRIP
44
-10
RCL
79
-5
ORLY
56
-8
CMCSA
46
-3
BXP
42
-8
KLAC
70
-4
MET
66
-7
GM
74
-8
WFC
72
-8
IBM
57
-7
GILD
60
-3
SJM
21
-8
NWSA
79
-3
ADSK
62
-5
USB
64
-9
AAP
20
-7
MLM
50
-14
KEY
60
-7
MU
62
-2
HBAN
74
-10
TRIP
44
-10
RCL
79
-5
ORLY
56
-8
CMCSA
46
-3
BXP
42
-8
KLAC
70
-4
MET
66
-7
GM
74
-8
WFC
72
-8
IBM
57
-7
Financhill
Back

Givaudan SA Vs. Sarepta Therapeutics Industry Stock Comparison

Buy
82

GVDNY
Givaudan SA

Last Price:
$98.03
Seasonality Move:
4.12%
Sell
49

SRPT
Sarepta Therapeutics

Last Price:
$38.82
Seasonality Move:
2.85%
Buy
82
Givaudan SA (GVDNY) is a Buy

Is Givaudan SA a Buy, Sell or Hold?

  • The current Givaudan SA [GVDNY] share price is $99.17. The Score for GVDNY is 82, which is 64% above its historic median score of 50, and infers lower risk than normal.
  • GVDNY is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
Sell
49
Sarepta Therapeutics (SRPT) is a Sell

Is Sarepta Therapeutics a Buy, Sell or Hold?

  • The current Sarepta Therapeutics [SRPT] share price is $40.05. The Score for SRPT is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
  • SRPT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

GVDNY Stock Price Chart

What is Givaudan SA's stock price today?

  • The Givaudan SA share price today is $99.17
    The current trend is moderately bullish and GVDNY is experiencing selling pressure, which indicates risk of future bearish movement.

SRPT Stock Price Chart

What is Sarepta Therapeutics's stock price today?

  • The Sarepta Therapeutics share price today is $40.05
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SRPT is experiencing selling pressure, which indicates risk of future bearish movement.

GVDNY Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 1.84 Buy
Relative Strength Index (14 RSI): 64.36 Buy
Chaikin Money Flow: -8606 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (93.13 - 98.05) Buy
Bollinger Bands (100): (85.52 - 93.86) Buy

SRPT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -7.04 Sell
Relative Strength Index (14 RSI): 33.73 Sell
Chaikin Money Flow: -8069571 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (37.85 - 60.79) Sell
Bollinger Bands (100): (56.32 - 117.26) Sell

GVDNY Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 96.97 Buy
20-day SMA: 96.45 Buy
50-day SMA: 92.04 Buy
200-day SMA: 93.44 Buy
8-day EMA: 97.82 Buy
20-day EMA: 96.13 Buy
50-day EMA: 93.3 Buy
200-day EMA: 91.18 Buy

SRPT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 37.25 Buy
20-day SMA: 47.56 Sell
50-day SMA: 59.29 Sell
200-day SMA: 106.93 Sell
8-day EMA: 39.29 Buy
20-day EMA: 45.05 Sell
50-day EMA: 59.91 Sell
200-day EMA: 95.91 Sell

Givaudan SA Earnings Growth & GVDNY Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.74 per share, an increase next quarter of $0.95 per share, a decrease this year of $3.92 per share, and an increase next year of $7.74 per share.

Givaudan SA Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Sarepta Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):